Indication
Charcot-Marie-Tooth Neuropathy Type 1A
1 clinical trial
1 product
Clinical trial
Phase I/IIa Trial Evaluating scAAV1.tMCK.NTF3 for Treatment of Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A)Status: , Estimated PCD: 2028-04-01
Product
scAAV1.tMCK.NTF3